Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle.

Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Abstract Text:

M S Radin,S Sinha,B A Bhatt,N Dedousis,R M O'Doherty,

AIMS/HYPOTHESIS: A role for increased activity of the innate immune system in the pathogenesis of insulin resistance is supported by a number of studies. The current study assessed the potential role of the lipopolysaccharide receptor known as Toll-like receptor-4 (TLR-4), a component of the innate immune system, in mediating lipid-induced insulin resistance in skeletal muscle. METHODS: The effects of TLR-4 inhibition/deletion on lipid-induced insulin resistance was determined in skeletal muscle of TLR-4 null mice in vivo and in rat L6 myotubes in vitro. RESULTS: In mice, acute hyperlipidaemia induced skeletal muscle insulin resistance, but a deletion of TLR-4 conferred significant protection against these effects. In L6 myotubes, inhibition of TLR-4 activity substantially reduced the capacity of the saturated fatty acid palmitate to induce insulin resistance. Importantly, palmitate activated the nuclear factor kappaB (NFkappaB) pathway in L6 myotubes and mouse skeletal muscle, and these effects were blocked by inhibition of TLR-4 in L6 myotubes and absence of TLR-4 in skeletal muscle. Furthermore, inhibition of the NFkappaB pathway downstream of TLR-4 in L6 myotubes also protected against the induction of insulin resistance by palmitate. CONCLUSIONS/INTERPRETATION: Inhibition or absence of TLR-4 confers protection against the detrimental effects of lipids on skeletal muscle insulin action, and these effects are associated with a prevention of the activation of the NFkappaB pathway by lipids. Importantly, inhibition of the NFkappaB pathway in myotubes downstream of TLR-4 also protects against lipid-induced insulin resistance, suggesting a mechanism by which reduced TLR-4 activity confers beneficial effects on insulin action.

Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Publishing Authors By Initials

MS Radin,S Sinha,BA Bhatt,N Dedousis,RM O'Doherty,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Diabetologia

VOLUME: 51

Page Numbers: 336-46

Journal Abbreviation: Diabetologia

ISSN: 0012-186X

DAY: 1

MONTH: 12

YEAR: 2007

Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 6777

Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle.

AFFILIATION: Department of Medicine, Division of Endocrinology, University of Pittsburgh, Pittsburgh, PA, USA.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Diabetologia

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle Related Publications

• A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
• A new hearing test applicable to the crying newborn infant.
• A palladium-catalyzed glycosylation reaction: the de novo synthesis of natural and unnatural glycosides.
• A stereoselective synthesis of digitoxin and digitoxigen mono- and bisdigitoxoside from digitoxigenin via a palladium-catalyzed glycosylation.
• Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells.
• Anterior tibial artery pseudoaneurysm in a patient with hemophilia: a complication of ankle arthroscopy.
• De Novo Asymmetric Synthesis of 8a-epi-Swainsonine.
• De novo approach to 2-deoxy-beta-glycosides: asymmetric syntheses of digoxose and digitoxin.
• De novo asymmetric syntheses of SL0101 and its analogues via a palladium-catalyzed glycosylation.
• De novo asymmetric syntheses of muricatacin and its analogues via dihydroxylation of dienoates.
• De novo asymmetric synthesis of milbemycin beta3 via an iterative asymmetric hydration approach.
• De novo asymmetric synthesis of the anthrax tetrasaccharide by a palladium-catalyzed glycosylation reaction.
• De novo formal synthesis of (-)-apicularen A via an iterative asymmetric hydration sequence.
• De novo formal synthesis of (-)-virginiamycin M2 via the asymmetric hydration of dienoates.
• De novo synthesis of 2-substituted syn-1,3-diols via an iterative asymmetric hydration strategy.
• De novo synthesis of oligosaccharides using a palladium-catalyzed glycosylation reaction.
• Determining the neural substrates of goal-directed learning in the human brain.
• Glucuronidase and lipids in wallerian degeneration.
• HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration.
• Imaging neuroendocrine tumours with radionuclide techniques.
• Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle.
• Lights, camembert, action! The role of human orbitofrontal cortex in encoding stimuli, rewards, and choices.
• Positron emission tomography and the orthopaedic surgeon.
• Preparation and stability of a radioiodinated pentamidine isethionate analog.
• Reinforcement learning signals in the human striatum distinguish learners from nonlearners during reward-based decision making.
• Synthesis of aza-analogues of the glycosylated tyrosine portion of mannopeptimycin-E.
• The de novo synthesis of oligosaccharides: application to the medicinal chemistry SAR-study of digitoxin.
• The influence of manure composition on emissions of odour and ammonia from finishing pigs fed different concentrations of dietary crude protein.
• [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
• [Sinterloy technic. Ceramic framework of metallic powder]